In utero and early infancy exposure to diagnostic X-rays may increase the risk for childhood cancers, according to research published online Feb. 10 in BMJ.
FRIDAY, Feb. 11 (HealthDay News) -- In utero and early infancy exposure to diagnostic X-rays may increase the risk for childhood cancers, according to research published online Feb. 10 in BMJ.
Preetha Rajaraman, Ph.D., of the National Institutes of Health in Bethesda, Md., and colleagues studied 2,690 children with cancer and 4,858 matched controls to examine the cancer risks associated with in utero and early infancy diagnostic radiation and ultrasound exposure.
The researchers found no evidence of an association between in utero exposure to ultrasound scans and childhood cancer, but some indication that in utero X-ray exposure might slightly raise the risk for all cancers and leukemia, though this was not statistically significant. X-ray exposure in early infancy was associated with a slightly higher, nonsignificant excess risk for all cancers and leukemia, and an increased risk for lymphoma based on small numbers (just seven cases).
"Although the results for lymphoma need to be replicated, all of the findings indicate possible risks of cancer from radiation at doses lower than those associated with commonly used procedures such as computed tomography scans, suggesting the need for cautious use of diagnostic radiation imaging procedures to the abdomen/pelvis of the mother during pregnancy and in children at very young ages," the authors write.
Related Content
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More